Chromosomal abnormalities in Ph- cells of patients on imatinib

被引:17
作者
McMullin, MF [1 ]
Humphreys, M [1 ]
Byrne, J [1 ]
Russell, NH [1 ]
Cuthbert, RJ [1 ]
O'Dwyer, ME [1 ]
机构
[1] Belfast City Hosp, Belfast BT9 7AB, Antrim, North Ireland
关键词
D O I
10.1182/blood-2003-06-1943
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2700 / 2701
页数:2
相关论文
共 7 条
[1]   Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8 [J].
Andersen, MK ;
Pedersen-Bjorgaard, J ;
Kjeldsen, L ;
Dufva, IH ;
Brondum-Nielsen, K .
LEUKEMIA, 2002, 16 (07) :1390-1393
[2]   Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority [J].
Bumm, T ;
Müller, C ;
Al-Ali, HK ;
Krohn, K ;
Shepherd, P ;
Schmidt, E ;
Leiblein, S ;
Franke, C ;
Hennig, E ;
Friedrich, T ;
Krahl, R ;
Niederwieser, D ;
Deininger, MWN .
BLOOD, 2003, 101 (05) :1941-1949
[3]   Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor [J].
Heinrich, MC ;
Griffith, DJ ;
Druker, BJ ;
Wait, CL ;
Ott, KA ;
Zigler, AJ .
BLOOD, 2000, 96 (03) :925-932
[4]   c-kit ligand and flt3 ligand:: Stem/progenitor cell factors with overlapping yet distinct activities [J].
Lyman, SD ;
Jacobsen, SEW .
BLOOD, 1998, 91 (04) :1101-1134
[5]   Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia [J].
O'Brien, SG ;
Guilhot, F ;
Larson, RA ;
Gathmann, I ;
Baccarani, M ;
Cervantes, F ;
Cornelissen, JJ ;
Fischer, T ;
Hochhaus, A ;
Hughes, T ;
Lechner, K ;
Nielsen, JL ;
Rousselot, P ;
Reiffers, J ;
Saglio, G ;
Shepherd, J ;
Simonsson, B ;
Gratwohl, A ;
Goldman, JM ;
Kantarjian, H ;
Taylor, K ;
Verhoef, G ;
Bolton, AE ;
Capdeville, R ;
Druker, BJ ;
Durrant, S ;
Schwarer, A ;
Joske, D ;
Seymour, J ;
Grigg, A ;
Ma, D ;
Arthur, C ;
Bradstock, K ;
Joshua, D ;
Louwagie, A ;
Martiat, P ;
Straetmans, N ;
Bosly, A ;
Shustik, C ;
Lipton, J ;
Forrest, D ;
Walker, I ;
Roy, DC ;
Rubinger, M ;
Bence-Bruckler, I ;
Kovacs, M ;
Turner, AR ;
Birgens, H ;
Bjerrum, O ;
Facon, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (11) :994-1004
[6]   Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate [J].
O'Dwyer, ME ;
Gatter, KM ;
Loriaux, M ;
Druker, BJ ;
Olson, SB ;
Magenis, RE ;
Lawce, H ;
Mauro, MJ ;
Maziarz, RT ;
Braziel, RM .
LEUKEMIA, 2003, 17 (03) :481-487
[7]   Regulation of cell death by the Abl tyrosine kinase [J].
Wang, JYJ .
ONCOGENE, 2000, 19 (49) :5643-5650